HelenKentChewMD
Oncology • Sacramento, CAAssociate Professor, Internal Medicine, UC, Davis School of Medicine
Are you Dr. Chew?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 86 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2279 45th Street
Sacramento, CA 95817Phone+1 916-734-5959Fax+1 916-703-5265- Is this information wrong?
Summary
- Dr. Helen Chew, MD is an oncologist in Sacramento, California. She is currently licensed to practice medicine in California and Texas. She is affiliated with UC Davis Medical Center and Sacramento Veterans Affairs Medical Center.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1992 - 1995
- The University of Texas Health Science Center at San AntonioClass of 1991
Certifications & Licensure
CA State Medical License 2000 - 2026
TX State Medical License 1994 - 2001- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Join now to see all
Clinical Trials
- GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2003 Oct 01
- S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer Start of enrollment: 2004 Jun 01
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsA phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovari...Julia Manzo, Shannon Puhalla, Shalu Pahuja, Fei Ding, Yan Lin, Leonard Appleman, Hussein Tawbi, Ronald Stoller, James J Lee, Brenda Diergaarde, Brian F Kiesel, Jing Yu...> ;Cancer Chemotherapy and Pharmacology. 2022 May 1
- Erratum to 'Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patie...R Beechinor, A Palumbo, H K Chew, M Arora> ;ESMO Open. 2022 Apr 1
- 9 citationsPlanning for post-pandemic cancer care delivery: Recovery or opportunity for redesign?Pelin Cinar, Richard J. Bold, Bryn A. Bosslet, Daniela A. Bota, Debra Burgess, Helen K. Chew, Joshua G. Cohen, Emad Elquza, Kathryn A. Gold, Emi Kamiya, Beth Y. Karlan...> ;CA. 2021 Jan 1
- Join now to see all
Press Mentions
Comprehensive Care and Patient-Doctor Partnership Helps Woman with CancerMarch 28th, 2022- Reduced Cancer Screenings Due to COVID-19 Fears May Result in Serious Health OutcomesFebruary 23rd, 2021
- A Medical School That Looks More like CaliforniaFebruary 28th, 2024
Grant Support
- A Phase II Study Of Gti-2440 (Nsc 722929) In Combination W/ Capecitabine In MetaNational Center For Research Resources2004
- Venous Thromboembolism Among California Cancer PatientsNational Cancer Institute2002–2003
Professional Memberships
- Member
- Fellow
Hospital Affiliations
UC Davis Medical CenterSacramento, California
Sacramento Veterans Affairs Medical CenterMather, California
